Cardiometabolic
Multi-organ phenotyping for the whole-body question.
Cardiometabolic disease never affects just one organ. CoverScan delivers a quantitative readout of liver, kidneys, pancreas, spleen, heart and lungs in a single MRI appointment, the right substrate for T2D, NASH-DM, and the cardiovascular-risk programmes following the Seboka AJPC 2026 long-COVID cardiac meta-analysis.
The UKIDS study is evaluating MRI as a cardiovascular-risk identifier in adults with diabetes, an early example of where this work is heading.
UKIDS · 1,000+ patient enrolment5 current cardiometabolic programmes
